Antibacterial agents in infections of the central nervous system

Infectious Disease Clinics of North America

Volumn 14, Issue 2, 2000, Pages 391-408

  Chowdhury, Mashiul H ^a   Tunkel, Allan R ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFMENOXIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; DEXAMETHASONE; DOXYCYCLINE; GATIFLOXACIN; MEROPENEM; MINOCYCLINE; MONOBACTAM DERIVATIVE; NAFCILLIN; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VANCOMYCIN;

ACTIVE TRANSPORT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG PENETRATION; HUMAN; IONIZATION; LIPOPHILICITY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN BINDING; REVIEW; TREATMENT INDICATION;

EID: 0034030510     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0891-5520(05)70254-3     Document Type: Review

References (85)

1. A. Ahmed M.M. Paris M. Trujillo Once-daily gentamicin therapy for experimental Escherichia coli meningitis Antimicrob Agents Chemother 41 1997 49
2. D.R. Andes W.A. Craig Pharmacokinetics and pharmacodynamics of antibiotics in meningitis Infect Dis Clin North Am 13 1999 95
3. P.C. Appelbaum Antimicrobial resistance in Streptococcus pneumoniae: An overview Clin Infect Dis 15 1992 77
4. M. Arditi B.C. Herold R. Yogev Cefuroxime treatment failure and Haemophilus influenzae meningitis: Case report and review of the literature Pediatrics 84 1989 132
5. J.S. Bradley J.D. Connor Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics Pediatr Infect Dis J 10 1991 871
6. A. Brunen W. Peetermans J. Verhaegen Meningitis due to Neisseria meningitidis with intermediate susceptibility to penicillin Eur J Clin Microbiol Infect Dis 12 1993 969
7. J.C. Butler J. Hofmann M.S. Cetron The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance working group J Infect Dis 174 1996 986
8. J. Campos S. Garcia-Tornel J.M. Gairi Multiply resistant Haemophilus influenzae type b causing meningitis: Comparative clinical and laboratory study J Pediatr 108 1989 897
9. J. Casado-Flores B. Osona P. Comingo Meningococcal meningitis during penicillin therapy for meningococcemia Clin Infect Dis 25 1997 1479
10. Centers for Disease Control and Prevention Geographic variation in penicillin resistance in Streptococcus pneumoniae —selected sites, United States, 1997 MMWR 48 1999 656
11. C.E. Cherubin M.D. Appleman P.N.R. Heseltine Epidemiological spectrum and current treatment of listeriosis Rev Infect Dis 13 1991 1108
12. C.E. Cherubin R.H.K. Eng R. Norrby Penetration of newer cephalosporins into cerebrospinal fluid Rev Infect Dis 11 1989 526
13. V. Chmelik J. Gutvirth Meropenem treatment of post-traumatic meningitis due to Pseudomonas aeruginosa J Antimicrob Chemother 32 1993 922
14. M. Cruciani A. Navarra Di Perri G. Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections Clin Infect Dis 15 1992 285
15. C.L. Cubells J.G. Garcia J.R. Martinez Clinical data in children with meningococcal meningitis in a Spanish hospital Acta Paediatr 86 1997 26
16. Dacey R.G. Jr M.A. Sande Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives Antimicrob Agents Chemother 6 1974 437
17. J.P. Donnelly A.M. Horrevorts R.W. Sauerwein High-dose meropenem in meningitis due to Pseudomonas aeruginosa Lancet 339 1992 1117
18. Fang GD, Loebenberg D, Scheld WM: Comparative efficacy of ziracin (SCH 27899, ZIR) in highly penicillin-resistant Streptococcus pneumoniae (PRSP) experimental meningitis in rabbits [abstract 1786]. In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999, p 81
19. Fang GD, Rosen H, Scheld WM: Comparative efficacy of L-749,345 (L-345) alone and in combination with vancomycin against highly penicillin-resistant Streptococcus pneumoniae (PRSP) experimental meningitis in rabbits [abstract 1785]. In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999, p 81
20. A.M.S. Figueiredo J.D. Connor A. Severin A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone Antimicrob Agents Chemother 36 1992 886
21. I.W. Fong K.B. Tomkins Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime Rev Infect Dis 7 1985 604
22. I.R. Friedland G.R. Istre Management of penicillin-resistant pneumococcal infections Pediatr Infect Dis J 11 1992 433
23. I.R. Friedland K.P. Klugman Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis Lancet 339 1992 40
24. I.R. Friedland M. Paris S. Ehrett Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 37 1993 1630
25. I.R. Friedland S. Shelton M. Paris Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis Pediatr Infect Dis J 12 1993 196
26. M. Galimand G. Gerbaud M. Guibourdenche High level chloramphenicol resistance in Neisseria meningitidis N Engl J Med 339 1998 868
27. M.E. Garci-Leoni E. Cerenado P. Rodeno Susceptibility of Steptococcus pneumoniae to penicillin: A prospective microbiological and clinical study Clin Infect Dis 14 1992 427
28. Gerber J, Yamini P, Nau R: After pretreatment by rifampin, ceftriaxone releases smaller quantities of lipoteichoic and teichoic acids (LTA/TA) from Streptococcus pneumoniae than ceftriaxone alone [abstract 1788]. In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999, p 82
29. L.B. Givner J.S. Abramson B. Wasilauskas Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol Rev Infect Dis 11 1989 329
30. L.Z. Glodani Inducement of Neisseria meningitidis resistance to ampicillin and penicillin in a patient with meningococcemia treated with high doses of ampicillin Clin Infect Dis 26 1998 772
31. D.W. Hass C.W. Stratton J.P. Griffin Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae Clin Infect Dis 20 1995 671
32. D.L. Hatch G.D. Overturf Delayed cerebrospinal fluid sterilization in infants with Haemophilus influenzae type b meningitis J Infect Dis 160 1989 711
33. Hopkins S, Williams D, Dunne M, et al: A randomized, controlled trial of oral and IV trovafloxacin vs. ceftriaxone in the treatment of epidemic meningococcal meningitis. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, 1996
34. L.A. Jackson F.C. Tenover C. Baker Prevalence of relatively resistant Neisseria meningitidis to penicillin in the United States, 1991 J Infect Dis 169 1994 438
35. J.H. Jorgensen Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae Clin Infect Dis 14 1992 1119
36. S.L. Kaplan C.C. Patrick Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms Pediatr Infect Dis J 9 1990 810
37. B.A. Kaufman A.R. Tunkel J.C. Pryor Meningitis in the neurosurgical patient Infect Dis Clin North Am 4 1990 677
38. K.P. Klugman R. Dagan The Meropenem Meningitis Study Group Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis Antimicrob Agents Chemother 39 1995 1140
39. U. Koedel H.W. Pfister Models of experimental meningitis: Role and limitations Infect Dis Clin North Am 13 1999 549
40. M.H. Lebel M.J. Hoyt McCracken G.H. Jr Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis J Pediatr 114 1989 1049
41. Lebel M.H. McCracken G.H. Jr Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children Pediatrics 83 1989 161
42. I. Lutsar I.R. Friedland G.H. McCracken Efficacy of gatifloxacin in experimental Escherichia coli meningitis Antimicrob Agents Chemother 43 1999 1805
43. I. Lutsar I.R. Friedland L. Wubbel Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 42 1998 2650
44. I. Lutsar G.H. McCracken I.R. Friedland Antibiotic pharmacodynamics in cerebrospinal fluid Clin Infect Dis 27 1998 1117
45. C.C. McCoig L. Wubbel I. Lutsar Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: Basis for dosage selection in children with meningitis J Antimicrob Chemother 43 1999 683
46. L.K. McDougal R. Facklam M. Reeves Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States Antimicrob Agents Chemother 36 1992 2176
47. P.M. Mendelman D.O. Chaffin L.R. Krilov Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins J Infect Dis 162 1990 1118
48. C. Michelet S.L. Leib D. Bentue-Ferrer Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes Antimicrob Agents Chemother 43 1999 1651
49. R. Munoz T.J. Coffey M. Daniels Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae J Infect Dis 164 1991 302
50. R. Nau A. Wellmer A. Soto Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis J Infect Dis 179 1999 1557
51. C.M. Odio J.R. Puig J.M. Feris Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group Pediatr Infect Dis J 18 1999 581
52. B.A. Odland R.N. Jones J. Verhoef Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY antimicrobial surveillance group Diagn Microbiol Infect Dis 34 1999 315
53. O'Ryan M, Saez-Llorens X, Santos JI, et al: Cefepime vs. ceftriaxone for pediatric meningitis. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996, p 284
54. J. Peltola M. Anttila O.V. Renkonen Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis Lancet 1 1989 1281
55. V.J. Quagliarello W.J. Long W.M. Scheld Morphologic alterations of the blood brain barrier with experimental meningitis in the rat J Clin Invest 77 1986 1084
56. S.J. Richards C.M. Lambert A.C. Scott Recurrent Listeria monocytogenes meningitis treated with intraventricular vancomycin J Antimicrob Chemother 29 1992 351
57. D. Rodoni F. Hanni C. Gerber Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model Antimicrob Agents Chemother 43 1999 963
58. W.J. Rodriguez W.N. Khan D.M. Cocchetto Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy Pediatr Infect Dis J 9 1990 83
59. Rodriguez-Cerrato V, Michelow IC, Ghaffar MF, et al: Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis [abstract 29]. In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999, p 9
60. X. Saez-Llorens E. Castano R. Garcia Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children Antimicrob Agents Chemother 39 1995 937
61. X. Saez-Llorens G.H. McCracken Antimicrobial and anti-inflammatory treatment of bacterial meningitis Infect Dis Clin North Am 13 1999 619
62. J.A. Saez-Nieto R. Lujan S. Berron Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: A 5-year history (1985–1989) Clin Infect Dis 14 1992 394
63. U.B. Schaad S. Suter A. Gianella-Borradori A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children N Engl J Med 322 1990 141
64. W.M. Scheld J.P. Brodeur Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis Antimicrob Agents Chemother 23 1983 108
65. W.M. Scheld M.A. Sande Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits J Clin Invest 71 1983 411
66. L.S. Schlesinger S.C. Ross D.R. Schaberg Staphylococcus aureus meningitis: A broad-based epidemiologic study Medicine 66 1987 148
67. T. Schmidt J. Froula M.G. Täuber Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis J Antimicrob Chemother 32 1993 627
68. T. Schmidt M.G. Täuber Pharmacodynamics of antibiotics in the therapy of meningitis: Infection model observations J Antimicrob Chemother 31 D 1993 61
69. E. Schmutzhard K.J. William G. Vukmirovits A randomized comparison of meropenem with cefotaxime and ceftriaxone for treatment of bacterial meningitis in adults J Antimicrob Chemother 36 suppl A 1995 85
70. D. Schuchat K. Robinson J.D. Wenger Bacterial meningitis in the United States in 1995 N Engl J Med 337 1997 970
71. M.M. Sloas F.F. Barrett P.J. Chesney Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis Pediatr Infect Dis J 11 1992 622
72. J.H. Song N.Y. Lee S. Ichiyama Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP) study Clin Infect Dis 28 1999 1206
73. R. Spector Advance in understanding the pharmacology of agents used to treat bacterial meningitis Pharmacology 41 1990 113
74. T.Q. Tan G.E. Schutze Mason E.O. Jr Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins Antimicrob Agents Chemother 38 1994 918
75. D. Thea M. Barza Use of antibacterial agents in infections of the central nervous system Infect Dis Clin North Am 3 1989 553
76. Trallero E.P. Garcia Arenzana J.M. I. Ayestaran Comparative activity in vitro of 16 antimicrobial agents against penicillin-susceptible meningococci and meningococci with diminished susceptibility to penicillin Antimicrob Agents Chemother 33 1989 1622
77. A.R. Tunkel W.M. Scheld Applications of therapy in animal models to bacterial infection in human disease Infect Dis Clin North Am 3 1989 441
78. A.R. Tunkel W.M. Scheld Treatment of bacterial meningitis Wolfson J.S. Hooper D.C. Quinolone Antimicrobial Agents 1993 American Society for Microbiology Washington, DC 481
79. A.R. Tunkel W.M. Scheld Acute meningitis Mandell G.L. Bennett J.E. Dolin R. Principles and Practice of Infectious Diseases ed 5 1999 Churchill Livingstone Philadelphia 959
80. P.F. Viladrich F. Gudiol J. Linares Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci Am J Med 84 1988 839
81. P.F. Viladrich F. Gudiol J. Linares Evaluation of vancomycin for therapy of adult pneumococcal meningitis Antimicrob Agents Chemother 35 1991 2467
82. K.B. Waites T. Rivers Bactericidal activities of ceftizoxime and cefotaxime against Streptococcus pneumoniae Antimicrob Agents Chemother 42 1998 1869
83. J.D. Wenger A.W. Hightower R.R. Facklam Bacterial meningitis in the United States, 1986: Report of a multistate surveillance study J Infect Dis 162 1990 1316
84. V.C. Weston J. Punt M. Vloebeghs Listeria monocytogenes meningitis in a penicillin-allergic paediatric renal transplant patient J Infect 37 1998 77
85. Wong V.K. Wright H.T. Jr L.A. Ross Imipenem/cilastatin treatment of bacterial meningitis in children Pediatr Infect Dis J 10 1991 122